• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Immun Inflamm Dis . The association between enteral nutrition with survival of critical patients with COVID-19

tetano

Editor, Senior Moderator
Immun Inflamm Dis


. 2024 May;12(5):e1261.
doi: 10.1002/iid3.1261. The association between enteral nutrition with survival of critical patients with COVID-19

Maryam Gholamalizadeh[SUP] 1 [/SUP], Zahra Salimi[SUP] 2 [/SUP], Khadijeh Abbasi Mobarakeh[SUP] 3 [/SUP], Zahra Mahmoudi[SUP] 4 [/SUP], Shirin Tajadod[SUP] 5 [/SUP], Mahdi Mousavi Mele[SUP] 6 [/SUP], Farkhondeh Alami[SUP] 7 [/SUP], Bojlul Bahar[SUP] 8 [/SUP], Saeid Doaei[SUP] 1 [/SUP], Sara Khoshdooz[SUP] 9 [/SUP], Masoume Rahvar[SUP] 10 [/SUP], Somayeh Gholami[SUP] 10 [/SUP], Masoume Pourtaleb[SUP] 10 [/SUP]



Affiliations
Abstract

Background: Coronavirus disease 2019 (COVID-19) results in several complications and mortality in intensive care unit (ICU) patients. Limited studies have investigated the effect of enteral nutrition (EN) on the survival of COVID-19 patients in the ICU. The aim of this study was to investigate the association of EN with biochemical and pathological indices associated with mortality in ICU patients with COVID-19.
Methods: This case-control study was conducted on 240 patients with COVID-19 hospitalized in the ICU including 120 eventual nonsurvived as the cases and 120 survived patients as the controls. All of the patients received EN as a high protein high volume or standard formula. Data on general information, anthropometric measurements, and the results of lab tests were collected.
Results: The recovered patients received significantly more high protein (60.8% vs. 39.6%, p = .004) and high volume (61.6% vs. 42.3%, p = .005) formula compared to the nonsurvived group. Mortality was inversely associated with high volume (odds ratio [OR]: 0.45 confidence interval [CI]95%, p = .008) and high protein (OR: 0.42 CI95%, p = .003) formula. The results remained significant after adjusting for age and sex. Further adjustment for underlying diseases, smoking, body mass index, and the acute physiology and chronic health evaluation II (APACHE II) score did not change the results.
Conclusion: The findings of the study showed that there was a significant inverse association between mortality and high volume and high protein formula in patients with COVID-19. Further investigation is warranted.

Keywords: COVID‐19; enteral nutrition; mortality; survival.

 
Back
Top Bottom